Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism

Overview of attention for article published in Blood, March 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog
twitter: 5 X users

patent: 4 patents
f1000: 1 research highlight platform

Citations

dimensions_citation: 146 Dimensions

Readers on

mendeley: 91 Mendeley

Summary News Blogs X Patents Research highlights Dimensions citations

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 11,419 followers.

6/ An emerging target for GVHD = ROCK2 inhibition. ROCKstar Trial https://t.co/8tACsGyryZ https://t.co/B2hk04emkI

22 Oct 2020

Reply Repost Favourite

@CapitiniMD Yes, in mice (https://t.co/iJ4k0BZR2d ). Lung ORR was 20% in dose escalation. Organ specific responses in phase 2 should be available soon.

21 Feb 2020

Reply Repost Favourite

Tfh | #Blood Targeted Rho-associated kinase 2 (ROCK2) inhibition decreases clinical and immune pathology of murine… https://t.co/YKo1MT3SY2

18 Mar 2016

Reply Repost Favourite

Targeted Rho-associated kinase 2 (ROCK2) inhibition decreases clinical and immune pathology of murine and human… https://t.co/GR500E3eXj

18 Mar 2016

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.